Astera Labs Shares Surge 10% on Amazon's $100B Deal with Anthropic
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy ALAB?
Source: seekingalpha
- Stock Surge: Astera Labs (ALAB) shares rose 10% during Tuesday morning trading, primarily driven by Amazon's (AMZN) $100 billion deal with Anthropic (ANTHRO), reflecting market optimism about its growth prospects.
- Analyst Rating: UBS initiated coverage of Astera Labs with a Neutral rating and a $180 price target, noting that while product quality and execution have been validated, high valuation and increasing competition warranted a cautious stance.
- Market Outlook: UBS analysts project that Astera Labs' revenues will exceed consensus by 4% over the next 2-3 years, primarily driven by its retimer products and expanded PCIe/UA Link switching portfolio, showcasing the company's ongoing innovation in technology.
- Competitive Risks: Although Astera Labs is expected to capture around 25% market share in the PCIe switching market by 2030, analysts highlight significant risks from strong competitors like Broadcom and Microchip, necessitating sustained high execution standards from the company.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALAB
Wall Street analysts forecast ALAB stock price to rise
19 Analyst Rating
14 Buy
5 Hold
0 Sell
Moderate Buy
Current: 175.800
Low
155.00
Averages
206.18
High
250.00
Current: 175.800
Low
155.00
Averages
206.18
High
250.00
About ALAB
Astera Labs, Inc. is a global semiconductor company. The Company provides semiconductor-based connectivity solutions for cloud and artificial intelligence (AI) infrastructure. It has developed and deployed its Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure. Its Intelligent Connectivity Platform provides its customers with the ability to deploy and operate high-performance cloud and AI infrastructure at scale, addressing an increasingly diverse set of requirements. It provides its connectivity products in various form factors, including Integrated Circuits (ICs), boards, and modules. Its PCIe, CXL and Ethernet semiconductor-based connectivity solutions are purpose-built to unleash the potential of accelerated computing at cloud-scale. The Company’s products include Aries products, which include its COSMOS software suite; Taurus products, which are hardware modules based on its Taurus ICs; Leo products; and Scorpio products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Astera Labs Shares Surge 10% on Amazon's $100B Deal with Anthropic
- Stock Surge: Astera Labs (ALAB) shares rose 10% during Tuesday morning trading, primarily driven by Amazon's (AMZN) $100 billion deal with Anthropic (ANTHRO), reflecting market optimism about its growth prospects.
- Analyst Rating: UBS initiated coverage of Astera Labs with a Neutral rating and a $180 price target, noting that while product quality and execution have been validated, high valuation and increasing competition warranted a cautious stance.
- Market Outlook: UBS analysts project that Astera Labs' revenues will exceed consensus by 4% over the next 2-3 years, primarily driven by its retimer products and expanded PCIe/UA Link switching portfolio, showcasing the company's ongoing innovation in technology.
- Competitive Risks: Although Astera Labs is expected to capture around 25% market share in the PCIe switching market by 2030, analysts highlight significant risks from strong competitors like Broadcom and Microchip, necessitating sustained high execution standards from the company.
See More
Astera Labs Stock Soars Following Amazon-Anthropic Deal
- Significant Stock Surge: Astera Labs (ALAB) shares surged over 8% on Tuesday, extending a remarkable rally that has seen the stock rise more than 60% in April, reflecting strong market optimism regarding suppliers linked to Amazon.
- Analyst Optimism: RBC raised its price target for Astera Labs from $225 to $250 while maintaining an 'Outperform' rating, indicating increased confidence in 2027 estimates and suggesting a 43% upside potential for the stock.
- Future Growth Challenges: UBS expressed a constructive outlook on Astera Labs' growth prospects over the next three years, although it noted that the company must compete in a more challenging switching market, highlighting intensifying market competition.
- Retail Trader Sentiment: Despite a 1,200% surge in message volume on Stocktwits within 24 hours, retail sentiment remains 'bullish', with one user predicting the company's market cap could double by year-end, currently around $30 billion.
See More
ASTERA LABS, INC: RBC Increases Target Price from $225 to $250
- Company Announcement: Aster Labs, Inc. has raised its price target for RBC to $250, up from a previous target of $225.
- Market Impact: This adjustment reflects a positive outlook on RBC's performance and potential growth in the market.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $70.46 Million in Common Stock via Form 144
Share Sale Announcement: Jitendra Mohan intends to sell 412.5K shares of Astera Labs on April 17, with a total market value of approximately $70.46 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 379.19K shares, valued at around $51.52 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $35.19 Million in Common Stock via Form 144
Stock Sale Announcement: Jitendra Mohan plans to sell 206.25K shares of Astera Labs on April 15, with a total market value of approximately $35.19 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 376.22K shares, valued at around $51 million.
See More
Astera Labs Shares Surge 10% on Amazon's $100B Deal with Anthropic
- Stock Surge: Astera Labs (ALAB) shares rose 10% during Tuesday morning trading, primarily driven by Amazon's (AMZN) $100 billion deal with Anthropic (ANTHRO), reflecting market optimism about its growth prospects.
- Analyst Rating: UBS initiated coverage of Astera Labs with a Neutral rating and a $180 price target, noting that while product quality and execution have been validated, high valuation and increasing competition warranted a cautious stance.
- Market Outlook: UBS analysts project that Astera Labs' revenues will exceed consensus by 4% over the next 2-3 years, primarily driven by its retimer products and expanded PCIe/UA Link switching portfolio, showcasing the company's ongoing innovation in technology.
- Competitive Risks: Although Astera Labs is expected to capture around 25% market share in the PCIe switching market by 2030, analysts highlight significant risks from strong competitors like Broadcom and Microchip, necessitating sustained high execution standards from the company.
See More
Astera Labs Stock Soars Following Amazon-Anthropic Deal
- Significant Stock Surge: Astera Labs (ALAB) shares surged over 8% on Tuesday, extending a remarkable rally that has seen the stock rise more than 60% in April, reflecting strong market optimism regarding suppliers linked to Amazon.
- Analyst Optimism: RBC raised its price target for Astera Labs from $225 to $250 while maintaining an 'Outperform' rating, indicating increased confidence in 2027 estimates and suggesting a 43% upside potential for the stock.
- Future Growth Challenges: UBS expressed a constructive outlook on Astera Labs' growth prospects over the next three years, although it noted that the company must compete in a more challenging switching market, highlighting intensifying market competition.
- Retail Trader Sentiment: Despite a 1,200% surge in message volume on Stocktwits within 24 hours, retail sentiment remains 'bullish', with one user predicting the company's market cap could double by year-end, currently around $30 billion.
See More
ASTERA LABS, INC: RBC Increases Target Price from $225 to $250
- Company Announcement: Aster Labs, Inc. has raised its price target for RBC to $250, up from a previous target of $225.
- Market Impact: This adjustment reflects a positive outlook on RBC's performance and potential growth in the market.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $70.46 Million in Common Stock via Form 144
Share Sale Announcement: Jitendra Mohan intends to sell 412.5K shares of Astera Labs on April 17, with a total market value of approximately $70.46 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 379.19K shares, valued at around $51.52 million.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $35.19 Million in Common Stock via Form 144
Stock Sale Announcement: Jitendra Mohan plans to sell 206.25K shares of Astera Labs on April 15, with a total market value of approximately $35.19 million.
Reduction in Holdings: Since February 17, 2026, Jitendra Mohan has reduced his shareholding in Astera Labs by 376.22K shares, valued at around $51 million.
See More
